Table 1.
Association between MALAT1 expression and clinicopathologic features of breast cancer.
| Characteristics | No | High expression of MALAT1 (%) | P value |
|---|---|---|---|
| Age | |||
| > 45 | 29 | 17 (42.0) | Ns |
| ≤ 45 | 21 | 13 (51.8) | |
| Estrogen receptor status | |||
| ER+ | 22 | 12 (52.1) | Ns |
| ER− | 28 | 18 (50.0) | |
| Tumor size (cm) | |||
| ≤ 2 | 23 | 13 (45.0) | Ns |
| > 2 | 27 | 17 (51.5) | |
| Her2/neu receptor status | |||
| Her2/neu+ | 23 | 15 (53.8) | Ns |
| Her2/neu− | 27 | 15 (47.2) | |
| Histologic subtype | |||
| Ductal | 27 | 17 (44.7) | Ns |
| Lobular | 23 | 13 (57.6) | |
| Lymph node involvement | |||
| Negative | 24 | 11 (34.0) | *P < 0.05 |
| Positive | 26 | 23 (60.8) | |
| Stage | |||
| I/II | 23 | 15 (43.0) | Ns |
| III | 27 | 15 (57.9) | |
| Progesterone receptor status | |||
| PR+ | 23 | 13 (51.4) | Ns |
| PR− | 27 | 17 (48.8) | |
Ns non-significant. *: significant